Peter Caravan
No bio available.
Financial relationships
-
Attribution:SelfType of financial relationship:StockIneligible company:Reveal PharmaceuticalsTopic:General purpose MRI Contrast agentsDate added:03/01/2022Date updated:03/01/2022
-
Attribution:SelfType of financial relationship:StockIneligible company:Collagen MedicakTopic:Molecular Imaging ProbesDate added:03/01/2022Date updated:03/01/2022
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:TakedaTopic:Imaging fibrosisDate added:03/01/2022Date updated:03/01/2022
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Pliant TherapeuticsTopic:Imaging fibrosisDate added:03/01/2022Date updated:03/01/2022
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:JanssenTopic:Imaging fibrosisDate added:03/01/2022Date updated:03/01/2022
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:CelgeneTopic:Imaging inflammationDate added:03/01/2022Date updated:03/01/2022
-
Attribution:Spouse or PartnerType of financial relationship:EmploymentIneligible company:Reveal PharmaceuticalsTopic:General purpose MRI Contrast agentsDate added:03/01/2022Date updated:03/01/2022
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.

Facebook
X
LinkedIn
Forward